Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Knowing what to include in an investment plan is vital for success. Explore essential tips to create a comprehensive investment strategy.
23,457 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Memory chips power AI and data centers, but prices swing with cycles. This guide weighs whether micron stock bubble r...
A large stake exit sent shockwaves through a payments stock, pulling it down by about half from its highs. This artic...
June brought a sharp pullback for software names, and figma stock lost june as AI disruption fears collided with rota...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...
The AI hype cycle has investors chasing the next breakout. This article identifies a stock I would avoid and a choice...
Memory industry dynamics are shifting, and Micron stands at the center. This piece breaks down why micron technology ...
This summer’s hottest IPOS are creating a surge of new wealth among employees and pressuring family offices to adapt ...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
D-Wave Quantum spiked on news of fresh government funding but ended lower as bulls and bears debated quantum advantag...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...